Rifamycin

  • 网络利福霉素;立复欣
RifamycinRifamycin
  1. Clinical therapeutic evaluation of rifamycin injection in treating acute serious infections

    利福霉素治疗急性严重感染的临床评价

  2. A study on the reactivity of rifamycin s and its structure - activity relationship

    利福霉素S的反应性和构效关系

  3. Objective : To observe the liver toxicity caused by Rifamycin .

    目的:观察立复欣的肝毒性。

  4. Preparation of McAbs against Rifamycin and Development of A Competitive ELISA Method

    利福霉素单克隆抗体的制备及竞争ELISA检测方法的建立

  5. Determination of Related Substances of Rifamycin Sodium Injection by HPLC

    HPLC法测定利福霉素钠注射液的有关物质

  6. Effect of System pH Value on the Rifamycin Oxazine Cyclization Reaction

    体系pH值对利福霉素恶嗪环合反应的影响

  7. Study on the Depressor Substance Test of Rifamycin Sodium Injection

    利福霉素钠注射液降压物质检查法研究

  8. Ion injection method used to select and cultivate rifamycin strain and the improvement of fermentation conditions

    硫酸庆大霉素注射液离子注射法选育利福霉素菌种与发酵条件优化

  9. Comparative clinical trial studies on cyclopentyl rifamycin in treatment for pulmonary tuberculosis

    利福喷丁治疗肺结核的临床对照研究

  10. Evaluation of efficacy and safety of rifamycin sodium injection in treatment of patients with pulmonary tuberculosis

    含利福霉素钠注射液方案治疗肺结核的有效性和安全性评价

  11. Uniform design method was employed to optimize the medium for production of rifamycin SV .

    应用均匀设计的方法对利福霉素SV发酵培养基中的氮源配比进行优化。

  12. Study of Rifamycin B Selection and Fermentation

    利福霉素B的选育及其发酵的研究

  13. Establishment and Its Application of a Fast Screening Method for Rifamycin SV-Producing Strain

    利福霉素高产菌株快速筛选方法的建立及应用

  14. Study on treating the separated fluid of rifamycin SV sodium scrap by electrolytic method

    电解法处理利福霉素SV钠废渣分离液的研究

  15. Optimization of Barbital Sodium Content during Fermentation of Rifamycin B

    利福霉素B发酵过程中巴比妥钠加量的优化

  16. Extraction process of rifamycin B from fermentation broth

    利福霉素B的提取工艺研究

  17. A preliminary study on separation of sodium salt of rifamycin s with macroporous adsorbent resin

    大孔吸附树脂法分离利福霉素S钠盐的初步探讨

  18. Serious side effects , which were mainly caused by rifamycin agents , occurred within 2 hours after administration .

    严重副反应绝大多数由利福霉素类引起;副作用出现时间多为服药后2个月以内;

  19. RESULTS : The clinical effective rate of rifamycin was 88 % , the bacterial clearance rate was 73 % .

    结果:利福霉素治疗的有效率88%,细菌清除率73%。

  20. Amikacin associated with rifamycin as the first-choice empirical treatment of community acquired bacterial lung infection

    阿米卡星与利福霉素钠注射液联合作为经验性治疗院外细菌性肺部感染首选方案的临床研究

  21. The relation between resistance of organisms to benzothiazole - rifamycin and membrane barrier of cells

    细菌对苯噻唑力复霉素的耐药性与细菌膜屏障的关系

  22. Observation of the liver toxicity of Rifamycin

    立复欣肝毒性临床观察

  23. The Technological Research on Preparation of Raw Protein Feed from the Medicinal Residue of Rifamycin SV Sodium Salt

    利福霉素SV钠盐药渣制取粗蛋白的工艺研究

  24. Study of retrieving protein from the waste dregs of rifamycin SV sodium by salting out method

    盐析法从利福霉素SV钠废渣中回收蛋白质的研究

  25. Rifapentine is a new type of semisynthetic antibiotic belonging to the rifamycin group .

    利福喷丁(rifapentine)是一种新型半合成的利福霉素类抗生素,与利福平具有相似的抗菌活性。

  26. Studies on the fermentation medium of Nocardia mediterranei producing rifamycin SV

    利福霉素产生菌发酵培养基的研究

  27. Rifamycin in treating community-acquired pulmonary infections in fifty-two patients

    利福霉素治疗社区获得性肺部感染52例

  28. Effect of Glycerol Addition on Rifamycin SV Biosynthesis

    甘油对利福霉素SV生物合成的影响

  29. A study on chloroform insoluble substances in Rifamycin

    利福霉素中氯仿不溶物的研究

  30. Retrieve the Coarse Protein from the Waste Dregs of Rifamycin SV Sodium Using High Molecular Polymer Inorganic Flocculant

    无机高分子絮凝剂处理利福平SV钠药渣回收粗蛋白